Using recombinant proteins from Lutzomyia longipalpis saliva to estimate human vector exposure in visceral Leishmaniasis endemic areas.
Leishmania is transmitted by female sand flies and deposited together with saliva, which contains a vast repertoire of pharmacologically active molecules that contribute to the establishment of the infection. The exposure to vector saliva induces an immune response against its components that can be...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-03-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC2843636?pdf=render |
id |
doaj-52283fe481ef4f05999c62dd4ad81776 |
---|---|
record_format |
Article |
spelling |
doaj-52283fe481ef4f05999c62dd4ad817762020-11-25T02:07:49ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352010-03-0143e64910.1371/journal.pntd.0000649Using recombinant proteins from Lutzomyia longipalpis saliva to estimate human vector exposure in visceral Leishmaniasis endemic areas.Ana Paula SouzaBruno Bezerril AndradeDorlene AquinoPetter EntringerJosé Carlos MirandaRuan AlcantaraDaniel RuizManuel SotoClarissa R TeixeiraJesus G ValenzuelaCamila Indiani de OliveiraCláudia Ida BrodskynManoel Barral-NettoAldina BarralLeishmania is transmitted by female sand flies and deposited together with saliva, which contains a vast repertoire of pharmacologically active molecules that contribute to the establishment of the infection. The exposure to vector saliva induces an immune response against its components that can be used as a marker of exposure to the vector. Performing large-scale serological studies to detect vector exposure has been limited by the difficulty in obtaining sand fly saliva. Here, we validate the use of two sand fly salivary recombinant proteins as markers for vector exposure.ELISA was used to screen human sera, collected in an area endemic for visceral leishmaniasis, against the salivary gland sonicate (SGS) or two recombinant proteins (rLJM11 and rLJM17) from Lutzomyia longipalpis saliva. Antibody levels before and after SGS seroconversion (n = 26) were compared using the Wilcoxon signed rank paired test. Human sera from an area endemic for VL which recognize Lu. longipalpis saliva in ELISA also recognize a combination of rLJM17 and rLJM11. We then extended the analysis to include 40 sera from individuals who were seropositive and 40 seronegative to Lu. longipalpis SGS. Each recombinant protein was able to detect anti-saliva seroconversion, whereas the two proteins combined increased the detection significantly. Additionally, we evaluated the specificity of the anti-Lu. longipalpis response by testing 40 sera positive to Lutzomyia intermedia SGS, and very limited (2/40) cross-reactivity was observed. Receiver-operator characteristics (ROC) curve analysis was used to identify the effectiveness of these proteins for the prediction of anti-SGS positivity. These ROC curves evidenced the superior performance of rLJM17+rLJM11. Predicted threshold levels were confirmed for rLJM17+rLJM11 using a large panel of 1,077 serum samples.Our results show the possibility of substituting Lu. longipalpis SGS for two recombinant proteins, LJM17 and LJM11, in order to probe for vector exposure in individuals residing in endemic areas.http://europepmc.org/articles/PMC2843636?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ana Paula Souza Bruno Bezerril Andrade Dorlene Aquino Petter Entringer José Carlos Miranda Ruan Alcantara Daniel Ruiz Manuel Soto Clarissa R Teixeira Jesus G Valenzuela Camila Indiani de Oliveira Cláudia Ida Brodskyn Manoel Barral-Netto Aldina Barral |
spellingShingle |
Ana Paula Souza Bruno Bezerril Andrade Dorlene Aquino Petter Entringer José Carlos Miranda Ruan Alcantara Daniel Ruiz Manuel Soto Clarissa R Teixeira Jesus G Valenzuela Camila Indiani de Oliveira Cláudia Ida Brodskyn Manoel Barral-Netto Aldina Barral Using recombinant proteins from Lutzomyia longipalpis saliva to estimate human vector exposure in visceral Leishmaniasis endemic areas. PLoS Neglected Tropical Diseases |
author_facet |
Ana Paula Souza Bruno Bezerril Andrade Dorlene Aquino Petter Entringer José Carlos Miranda Ruan Alcantara Daniel Ruiz Manuel Soto Clarissa R Teixeira Jesus G Valenzuela Camila Indiani de Oliveira Cláudia Ida Brodskyn Manoel Barral-Netto Aldina Barral |
author_sort |
Ana Paula Souza |
title |
Using recombinant proteins from Lutzomyia longipalpis saliva to estimate human vector exposure in visceral Leishmaniasis endemic areas. |
title_short |
Using recombinant proteins from Lutzomyia longipalpis saliva to estimate human vector exposure in visceral Leishmaniasis endemic areas. |
title_full |
Using recombinant proteins from Lutzomyia longipalpis saliva to estimate human vector exposure in visceral Leishmaniasis endemic areas. |
title_fullStr |
Using recombinant proteins from Lutzomyia longipalpis saliva to estimate human vector exposure in visceral Leishmaniasis endemic areas. |
title_full_unstemmed |
Using recombinant proteins from Lutzomyia longipalpis saliva to estimate human vector exposure in visceral Leishmaniasis endemic areas. |
title_sort |
using recombinant proteins from lutzomyia longipalpis saliva to estimate human vector exposure in visceral leishmaniasis endemic areas. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS Neglected Tropical Diseases |
issn |
1935-2727 1935-2735 |
publishDate |
2010-03-01 |
description |
Leishmania is transmitted by female sand flies and deposited together with saliva, which contains a vast repertoire of pharmacologically active molecules that contribute to the establishment of the infection. The exposure to vector saliva induces an immune response against its components that can be used as a marker of exposure to the vector. Performing large-scale serological studies to detect vector exposure has been limited by the difficulty in obtaining sand fly saliva. Here, we validate the use of two sand fly salivary recombinant proteins as markers for vector exposure.ELISA was used to screen human sera, collected in an area endemic for visceral leishmaniasis, against the salivary gland sonicate (SGS) or two recombinant proteins (rLJM11 and rLJM17) from Lutzomyia longipalpis saliva. Antibody levels before and after SGS seroconversion (n = 26) were compared using the Wilcoxon signed rank paired test. Human sera from an area endemic for VL which recognize Lu. longipalpis saliva in ELISA also recognize a combination of rLJM17 and rLJM11. We then extended the analysis to include 40 sera from individuals who were seropositive and 40 seronegative to Lu. longipalpis SGS. Each recombinant protein was able to detect anti-saliva seroconversion, whereas the two proteins combined increased the detection significantly. Additionally, we evaluated the specificity of the anti-Lu. longipalpis response by testing 40 sera positive to Lutzomyia intermedia SGS, and very limited (2/40) cross-reactivity was observed. Receiver-operator characteristics (ROC) curve analysis was used to identify the effectiveness of these proteins for the prediction of anti-SGS positivity. These ROC curves evidenced the superior performance of rLJM17+rLJM11. Predicted threshold levels were confirmed for rLJM17+rLJM11 using a large panel of 1,077 serum samples.Our results show the possibility of substituting Lu. longipalpis SGS for two recombinant proteins, LJM17 and LJM11, in order to probe for vector exposure in individuals residing in endemic areas. |
url |
http://europepmc.org/articles/PMC2843636?pdf=render |
work_keys_str_mv |
AT anapaulasouza usingrecombinantproteinsfromlutzomyialongipalpissalivatoestimatehumanvectorexposureinvisceralleishmaniasisendemicareas AT brunobezerrilandrade usingrecombinantproteinsfromlutzomyialongipalpissalivatoestimatehumanvectorexposureinvisceralleishmaniasisendemicareas AT dorleneaquino usingrecombinantproteinsfromlutzomyialongipalpissalivatoestimatehumanvectorexposureinvisceralleishmaniasisendemicareas AT petterentringer usingrecombinantproteinsfromlutzomyialongipalpissalivatoestimatehumanvectorexposureinvisceralleishmaniasisendemicareas AT josecarlosmiranda usingrecombinantproteinsfromlutzomyialongipalpissalivatoestimatehumanvectorexposureinvisceralleishmaniasisendemicareas AT ruanalcantara usingrecombinantproteinsfromlutzomyialongipalpissalivatoestimatehumanvectorexposureinvisceralleishmaniasisendemicareas AT danielruiz usingrecombinantproteinsfromlutzomyialongipalpissalivatoestimatehumanvectorexposureinvisceralleishmaniasisendemicareas AT manuelsoto usingrecombinantproteinsfromlutzomyialongipalpissalivatoestimatehumanvectorexposureinvisceralleishmaniasisendemicareas AT clarissarteixeira usingrecombinantproteinsfromlutzomyialongipalpissalivatoestimatehumanvectorexposureinvisceralleishmaniasisendemicareas AT jesusgvalenzuela usingrecombinantproteinsfromlutzomyialongipalpissalivatoestimatehumanvectorexposureinvisceralleishmaniasisendemicareas AT camilaindianideoliveira usingrecombinantproteinsfromlutzomyialongipalpissalivatoestimatehumanvectorexposureinvisceralleishmaniasisendemicareas AT claudiaidabrodskyn usingrecombinantproteinsfromlutzomyialongipalpissalivatoestimatehumanvectorexposureinvisceralleishmaniasisendemicareas AT manoelbarralnetto usingrecombinantproteinsfromlutzomyialongipalpissalivatoestimatehumanvectorexposureinvisceralleishmaniasisendemicareas AT aldinabarral usingrecombinantproteinsfromlutzomyialongipalpissalivatoestimatehumanvectorexposureinvisceralleishmaniasisendemicareas |
_version_ |
1724929420142051328 |